Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Changes in SFRP5, WNT5A, HbA1c, BMI, PBF, and insulin resistance in men with type 2 diabetes after 12 weeks of combined exercise (HIIT and resistance)

Abstract

Background

Secreted frizzled-related protein 5 (SFRP5) and WNT family member 5A (WNT5A) have been found to associate with glucose metabolism and insulin sensitivity through noncanonical WNT signaling. The purpose of this study was to investigate changes in SFRP5, WNT5A, glycated hemoglobin (HbA1c), body mass index (BMI), percentage body fat (PBF), and insulin resistance in men with type 2 diabetes after 12 weeks of combined exercise (high-intensity interval training (HIIT) and resistance) and examine the relationship between these variables in men with type 2 diabetes.

Methods

Nineteen men with type 2 diabetes (mean age of 58.3) were divided into two groups: experimental group (10 individuals) and control group (9 individuals). The experimental group performed 12 weeks of combined exercise (HIIT and resistance).

Results

Twelve weeks of combined exercise (HIIT and resistance) increased SFRP5 serum level and decreased WNT5A serum level, HbA1c, insulin resistance, BMI, and PBF in the intervention group compared with the control group. SFRP5 had a significant negative relationship with WNT5A, insulin resistance, BMI, and PBF. In addition, BMI had a significant positive relationship with WNT5A, insulin resistance, and PBF.

Conclusion

The improvement of type 2 diabetic men’s health can be a result of increased anti-inflammatory factor SFRP5 and decreased inflammatory factor WNT5A through reduction of BMI and PBF.

Trial registration

IRCT20151026024717N3

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Schäfer SA, Machicao F, Fritsche A, Häring H-U, Kantartzis K. New type 2 diabetes risk genes provide new insights in insulin secretion mechanisms. Diabetes Res Clin Pract. 2011;93:S9–S24.

  2. 2.

    Blüher PM. The inflammatory process of adipose tissue. Pediatr Endocrinol Rev. 2008;6(1):24–31.

  3. 3.

    Carstensen M, Herder C, Kempf K, Erlund I, Martin S, Koenig W, et al. Sfrp5 correlates with insulin resistance and oxidative stress. Eur J Clin Investig. 2013;43(4):350–7.

  4. 4.

    Bhat RA, Stauffer B, Komm BS, Bodine PV. Structure–function analysis of secreted frizzled-related protein-1 for its Wnt antagonist function. J Cell Biochem. 2007;102(6):1519–28.

  5. 5.

    Gholizadeh-Ghaleh Aziz S, Fathi E, Rahmati-Yamchi M, Akbarzadeh A, Fardyazar Z, Pashaiasl M. An update clinical application of amniotic fluid-derived stem cells (AFSCs) in cancer cell therapy and tissue engineering. Artif Cell Nanomed Biotechnol. 2017;45(4):765–74.

  6. 6.

    Ouchi N, Higuchi A, Ohashi K, Oshima Y, Gokce N, Shibata R, et al. Sfrp5 is an anti-inflammatory adipokine that modulates metabolic dysfunction in obesity. Science. 2010;329(5990):454–7.

  7. 7.

    Fayaz E, Damirchi A, Zebardast N, Babaei P. Co-treatment of cinnamon extract with high-intensity endurance training alleviates metabolic syndrome via noncanonical WNT signaling. Nutrition. 2019.

  8. 8.

    Kadam P, Bhalerao S. Sample size calculation. Int J Ayurveda Res. 2010;1(1):55.

  9. 9.

    Colberg SR, Sigal RJ, Fernhall B, Regensteiner JG, Blissmer BJ, Rubin RR, et al. Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement. Diabetes Care. 2010;33(12):e147–67.

  10. 10.

    Hordern MD, Dunstan DW, Prins JB, Baker MK, Singh MA, Coombes JS. Exercise prescription for patients with type 2 diabetes and pre-diabetes: a position statement from Exercise and Sport Science Australia. J Sci Med Sport. 2012;15(1):25–31.

  11. 11.

    Praet SF, Van Loon LJ. Optimizing the therapeutic benefits of exercise in type 2 diabetes. J Appl Physiol. 2007;103(4):1113–20.

  12. 12.

    Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–9.

  13. 13.

    Teliewubai J, Bai B, Zhou Y, Lu Y, Yu S, Chi C, et al. Association of asymptomatic target organ damage with secreted frizzled related protein 5 in the elderly: the northern Shanghai study. Clin Interv Aging. 2018;13:389.

  14. 14.

    Canivell S, Rebuffat SG, Ruano E, Kostov B, Sisó-Almirall A, Novials A, et al. Circulating SFRP5 levels are elevated in drug-naïve recently diagnosed type 2 diabetic patients as compared with prediabetic subjects and controls. Diabetes Metab Res Rev. 2015;31(2):212–9.

  15. 15.

    Catalán V, Gómez-Ambrosi J, Rodríguez A, Pérez-Hernández AI, Gurbindo J, Ramírez B, et al. Activation of noncanonical Wnt signaling through WNT5A in visceral adipose tissue of obese subjects is related to inflammation. J Clin Endocrinol Metab. 2014;99(8):E1407–E17.

  16. 16.

    Carstensen M, Wiza C, Röhrig K, Fahlbusch P, Roden M, Herder C, et al. Effect of Sfrp5 on cytokine release and insulin action in primary human adipocytes and skeletal muscle cells. PLoS One. 2014;9(1):e85906.

  17. 17.

    Hu W, Li L, Yang M, Luo X, Ran W, Liu D, et al. Circulating Sfrp5 is a signature of obesity-related metabolic disorders and is regulated by glucose and liraglutide in humans. J Clin Endocrinol Metab. 2013;98(1):290–8.

  18. 18.

    Schulte DM, Müller N, Neumann K, Oberhäuser F, Faust M, Güdelhöfer H, et al. Pro-inflammatory wnt5a and anti-inflammatory sFRP5 are differentially regulated by nutritional factors in obese human subjects. PLoS One. 2012;7(2):e32437.

  19. 19.

    Mori H, Prestwich TC, Reid MA, Longo KA, Gerin I, Cawthorn WP, et al. Secreted frizzled-related protein 5 suppresses adipocyte mitochondrial metabolism through WNT inhibition. J Clin Invest. 2012;122(7):2405–16.

  20. 20.

    Koza RA, Nikonova L, Hogan J, Rim J-S, Mendoza T, Faulk C, et al. Changes in gene expression foreshadow diet-induced obesity in genetically identical mice. PLoS Genet. 2006;2(5):e81.

  21. 21.

    Ehrlund A, Mejhert N, Lorente-Cebrián S, Åström G, Dahlman I, Laurencikiene J, et al. Characterization of the Wnt inhibitors secreted frizzled-related proteins (SFRPs) in human adipose tissue. The Journal of Clinical Endocrinology & Metabolism. 2013;98(3):E503–E8.

  22. 22.

    Hu Z, Deng H, Qu H. Plasma SFRP5 levels are decreased in Chinese subjects with obesity and type 2 diabetes and negatively correlated with parameters of insulin resistance. Diabetes Res Clin Pract. 2013;99(3):391–5.

  23. 23.

    Miyoshi T, Doi M, Usui S, Iwamoto M, Kajiya M, Takeda K, et al. Low serum level of secreted frizzled-related protein 5, an anti-inflammatory adipokine, is associated with coronary artery disease. Atherosclerosis. 2014;233(2):454–9.

  24. 24.

    Xu Q, Wang H, Li Y, Wang J, Lai Y, Gao L, et al. Plasma Sfrp5 levels correlate with determinants of the metabolic syndrome in Chinese adults. Diabetes Metab Res Rev. 2017;33(6):e2896.

  25. 25.

    Almario R, Karakas SE. Roles of circulating WNT-signaling proteins and WNT-inhibitors in human adiposity, insulin resistance, insulin secretion, and inflammation. Horm Metab Res. 2015;47(02):152–7.

  26. 26.

    Bilkovski R, Schulte DM, Oberhauser F, Gomolka M, Udelhoven M, Hettich MM, et al. Role of WNT-5a in the determination of human mesenchymal stem cells into preadipocytes. J Biol Chem. 2010;285(9):6170–8.

  27. 27.

    Bilkovski R, Schulte D, Oberhauser F, Mauer J, Hampel B, Gutschow C, et al. Adipose tissue macrophages inhibit adipogenesis of mesenchymal precursor cells via wnt-5a in humans. Int J Obes. 2011;35(11):1450–4.

  28. 28.

    Adabimohazab R, Garfinkel A, Milam EC, Frosch O, Mangone A, Convit A. Does inflammation mediate the association between obesity and insulin resistance? Inflammation. 2016;39(3):994–1003.

  29. 29.

    Gustafson B, Hammarstedt A, Hedjazifar S, Smith U. Restricted adipogenesis in hypertrophic obesity: the role of WISP2, WNT, and BMP4. Diabetes. 2013;62(9):2997–3004.

  30. 30.

    Fuster JJ, Zuriaga MA, Ngo DT-M, Farb MG, Aprahamian T, Yamaguchi TP, et al. Noncanonical Wnt signaling promotes obesity-induced adipose tissue inflammation and metabolic dysfunction independent of adipose tissue expansion. Diabetes. 2015;64(4):1235–48.

  31. 31.

    Watts K, Jones TW, Davis EA, Green D. Exercise training in obese children and adolescents. Sports Med. 2005;35(5):375–92.

  32. 32.

    Rodriguez A, Becerril S, Ezquerro S, Mendez-Gimenez L, Frühbeck G. Crosstalk between adipokines and myokines in fat browning. Acta Physiol. 2017;219(2):362–81.

  33. 33.

    Bracht CG, Delevatti RS, Kruel LFM. Combined training in the treatment of type 2 diabetes mellitus: a review. Health. 2017;9(12):1605.

  34. 34.

    Zhang L, Liu K, Han B, Xu Z, Gao X. The emerging role of follistatin under stresses and its implications in diseases. Gene. 2018;639:111–6.

  35. 35.

    Ounis OB, Elloumi M, Chiekh IB, Zbidi A, Amri M, Lac G, et al. Effects of two-month physical-endurance and diet-restriction programmes on lipid profiles and insulin resistance in obese adolescent boys. Diabetes Metab. 2008;34(6):595–600.

Download references

Author information

Correspondence to Mahtab Moazzami.

Ethics declarations

This research was conducted following an intervention study design and was approved by the Regional Scientific Ethics Committee, Ferdowsi University of Mashhad, in accordance with the ethical standards of the 1983 Helsinki declaration. The subjects of this study were 19 men with type 2 diabetes aged 50–60 years, BMI 25–30 kg/m2, who voluntarily participated in the study after obtaining a written consent.

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Mir, E., Moazzami, M., Bijeh, N. et al. Changes in SFRP5, WNT5A, HbA1c, BMI, PBF, and insulin resistance in men with type 2 diabetes after 12 weeks of combined exercise (HIIT and resistance). Int J Diabetes Dev Ctries (2020). https://doi.org/10.1007/s13410-019-00790-7

Download citation

Keywords

  • SFRP5
  • WNT5A
  • HbA1c
  • Exercise
  • Insulin resistance